Recent Quotes (30 days)

You have no recent quotes
chg | %

ImmunoVaccine Inc.  

(Public, CVE:IMV)   Watch this stock  
Find more results for IMV
Nov 25 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.35 - 1.50
Open     -
Vol / Avg. 0.00/147,516.00
Mkt cap 67.59M
P/E     -
Div/yield     -
EPS -0.07
Shares 90.02M
Beta 1.17
Inst. own     -
Oct 17, 2017
Immunovaccine Inc at Biotechnology Industry Organization (BIO) Investor Forum
Sep 12, 2017
Immunovaccine Inc at Rodman & Renshaw Global Investment Conference

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin - -6858.77%
Operating margin - -5697.84%
EBITD margin - -5466.41%
Return on average assets -59.67% -84.51%
Return on average equity -118.06% -252.27%
Employees 23 -
CDP Score - -


1344 Summer Street, Suite 412
+1-902-4921819 (Phone)
+1-902-4920888 (Fax)

Website links


Immunovaccine Inc is a Canada-based clinical-stage biopharmaceutical company. The Company develops products based on its vaccine enhancement platform with a primary focus on T lymphocytes (T cell) activating therapies for cancer. The Company's DepoVax adjuvanting/delivery platform produces immune response that has a specific and sustained immune effect and enables the Company to pursue vaccine candidates in cancer, infectious diseases and other vaccine applications. The DepoVax platform is used in multiple vaccine candidates, including over two-cancer vaccine candidates that have completed Phase I clinical trials. Its lead cancer vaccine, DPX- Survivac, is tested in a company-sponsored Phase II trial in lymphoma and a Phase Ib trial in ovarian cancer. Its infectious disease vaccine against respiratory syncytial virus (RSV) is in a Phase I clinical trial in Halifax, Nova Scotia.

Officers and directors

Andy Sheldon Chairman of the Board
Frederic Ors Chief Executive Officer, Director
Age: 42
Kimberly Stephens Chief Financial Officer, Corporate Secretary
Pierre Labbe CPA Chief Financial Officer
Age: 51
Gabriela Nicola Rosu Chief Medical Officer
Marc Mansour Ph.D. Director
Age: 39
Albert James Scardino Director
Age: 66
Shermaine Tilley Ph.D. Director
Wade K. Dawe Independent Director
James W. Hall Independent Director
Age: 65